J Med Microbiol 1969,2(3):261–278.PubMedCrossRef 23. Kayser FH: Methicillin-resistant

staphylococci 1965–75. Lancet 1975,2(7936):650–653.PubMedCrossRef 24. Lacey RW, Stokes A: Studies on recently isolated cultures of methicillin-resistant Staphylococcus aureus. J Gen Microbiol 1979,114(2):329–339.PubMedCrossRef 25. Rosdahl VT, Westh H, Jensen K: Antibiotic susceptibility and phage-type pattern of Staphylococcus aureus HKI-272 cost strains isolated from patients in general practice compared to strains from hospitalized patients. Scand J Infect Dis 1990,22(3):315–320.PubMedCrossRef 26. Hartman BJ, Tomasz A: Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol 1984,158(2):513–516.PubMedCentralPubMed 27. Hayes MV, Curits NAC, Wyke AW, Ward JB: Decreased affinity of a penicillin-binding protein for β-lactam antibiotics in a clinical isolate of Staphylococcus aureus resistant to methicillin. FEMS Microbiol Lett 1981,10(2):119–122. 28. Rossi L, Tonin E, Cheng YR, Fontana R: Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus. Antimicrob Agents Chemother 1985,27(5):828–831.PubMedCentralPubMedCrossRef

29. McDougal LK, Thornsberry C: The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986,23(5):832–839.PubMedCentralPubMed 30. Rosdahl VT: Penicillinase production in Staphylococcus aureus strains of clinical importance. Dan Med Bull 1986,33(4):175–184.PubMed 31. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri PCI-34051 in vivo P, Gerber MA, Tani LY,

Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Kawasaki D, Committee on Rheumatic Fever E: Sapanisertib supplier Infective endocarditis: selleck chemicals llc diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005,111(23):e394-e434.PubMedCrossRef 32. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995,274(21):1706–1713.PubMedCrossRef 33. Nannini EC, Stryjewski ME, Singh KV, Bourgogne A, Rude TH, Corey GR, Fowler VG Jr, Murray BE: Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother 2009,53(8):3437–3441.PubMedCentralPubMedCrossRef 34.